Peter S. Linsley
Publications by Year
Research Areas
Diabetes and associated disorders, Diabetes Management and Research, Pancreatic function and diabetes, RNA modifications and cancer, MicroRNA in disease regulation
Most-Cited Works
- → Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer(2001)1,288 cited
- → Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes(2018)213 cited
- → Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies(2007)187 cited
- → CTLA4Ig TREATMENT AMELIORATES THE LETHALITY OF MURINE GRAFT-VERSUS-HOST DISEASE ACROSS MAJOR HISTOCOMPATIBILITY COMPLEX BARRIERS(1994)117 cited
- → Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion(1996)20 cited
- → Mustering the micromanagers(2007)9 cited
- → Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model(1997)7 cited
- → Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189–2201(2022)1 cited
- → Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial(2023)
- → THU0033 ALTERATIONS IN THE PHENOTYPIC LANDSCAPE AND SPECIFICITY OF CD4+ T CELLS IN CCP+ AT RISK SUBJECTS BEFORE THE ONSET OF RHEUMATOID ARTHRITIS(2020)